Elite Pharmaceuticals, Inc. (ELTP)
Elite Pharmaceuticals Market Cap : 349.77M for Nov. 20, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2026 | 349.77M |
| November 19, 2026 | 348.88M |
| November 18, 2026 | 386.15M |
| November 17, 2026 | 398.16M |
| November 16, 2026 | 394.23M |
| November 13, 2026 | 349.96M |
| November 12, 2026 | 263.90M |
| November 11, 2026 | 258.51M |
| November 10, 2026 | 258.51M |
| November 09, 2026 | 255.09M |
| November 06, 2026 | 256.04M |
| November 05, 2026 | 254.29M |
| November 04, 2026 | 261.49M |
| November 03, 2026 | 261.64M |
| November 02, 2026 | 237.08M |
| October 30, 2026 | 247.63M |
| October 29, 2026 | 245.59M |
| October 28, 2026 | 263.79M |
| October 27, 2026 | 261.27M |
| October 26, 2026 | 268.42M |
| October 23, 2026 | 269.07M |
| October 22, 2026 | 266.59M |
| October 21, 2026 | 263.90M |
| October 20, 2026 | 264.17M |
| October 19, 2026 | 270.10M |
| Date | Value |
|---|---|
| October 16, 2026 | 273.86M |
| October 15, 2026 | 273.62M |
| October 14, 2026 | 268.42M |
| October 13, 2026 | 274.67M |
| October 12, 2026 | 274.67M |
| October 09, 2026 | 274.78M |
| October 08, 2026 | 285.44M |
| October 07, 2026 | 273.89M |
| October 06, 2026 | 263.90M |
| October 05, 2026 | 241.33M |
| October 02, 2026 | 246.29M |
| October 01, 2026 | 244.51M |
| September 30, 2026 | 260.45M |
| September 29, 2026 | 257.44M |
| September 28, 2026 | 270.79M |
| September 25, 2026 | 278.03M |
| September 24, 2026 | 265.82M |
| September 23, 2026 | 268.10M |
| September 22, 2026 | 266.00M |
| September 21, 2026 | 260.88M |
| September 18, 2026 | 266.59M |
| September 17, 2026 | 269.18M |
| September 16, 2026 | 263.89M |
| September 15, 2026 | 267.88M |
| September 14, 2026 | 279.84M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.570B |
| Corcept Therapeutics, Inc. | 6.958B |
| Veru, Inc. | 33.08M |
| Johnson & Johnson | 651.05B |
| Eli Lilly & Co. | 1.268T |
Market Cap Related Metrics
| PE Ratio | 11.72 |
| PS Ratio | 2.507 |
| PEG Ratio | 0.0297 |
| Price to Book Value | 2.863 |
| Price to Free Cash Flow | 41.63 |
| Price | 0.3247 |
| Earnings Yield | 8.53% |
| PEGY Ratio | 0.0297 |
| Operating PE Ratio | 9.677 |
| Normalized PE Ratio | 40.09 |